Skip to main content
. 2017 Apr 8;7(4):e012974. doi: 10.1136/bmjopen-2016-012974

Table 3.

Distribution of prescribed antibiotics according to class in four selected diagnoses groups at one teaching and one mon-teaching hospital in Ujjain, India

Cardiovascular with no registered bacterial infection Subgroup 1
Cardiovascular with suspected bacterial infection Subgroup 2
Malaria or viral fever with no registered bacterial infection Subgroup 3
Malaria or viral fever with suspected bacterial infection Subgroup 4
TH NTH p Value TH NTH p Value TH NTH p Value TH NTH p Value
Name of AB; ATC code n (%) n (%) n (%) n (%) n (%) n (%) n (%) n (%)
Total prescriptions 2741 3366 2388 855 3210 3451 316 128
Tetracyclines; J01A; J01AA 284 (10) 5 (0) <0.001 243 (10) 0 (0) 553 (17) 75 (2) <0.001 83 (26) 0 (0)
β-Lactam ABs, penicillin; J01C 456 (17) 498 (15) 0.041 622 (26) 184 (22) 0.009 111 (3) 245 (7) <0.001 12 (4) 7 (5) 0.431
 Extended-spectrum penicillins; J01CA 83 (3) 99 (3) 0.843 122 (5) 99 (12) <0.001 19 (1) 51 (1) <0.001 0 (0) 2 (2)
 Combination of penicillin including β-lactamase AB; J01CR 373 (14) 399 (12) 0.040 500 (21) 85 (10) <0.001 92 (3) 194 (6) <0.001 12 (4) 5 (4) 1.0†
Other β-lactams; J01D 496 (18) 1391 (41) <0.001 353 (15) 304 (36) <0.001 665 (21) 1792 (52) <0.001 40 (13) 39 (30) <0.001
 1st-generation cephalosporins; J01DB 7 (0) 16 (1) 0.163 0 (0) 5 (1) 0 (0) 9 (0) 0 (0) 0 (0)
 2nd-generation cephalosporins; J01DC 0 (0) 98 (3) 0 (0) 27 (3) 0 (0) 168 (5) 0 (0) 0 (0)
 3rd-generation cephalosporins; J01DD 481 (18) 1254 (37) <0.001 353 (15) 272 (32) <0.001 665 (21) 1606 (47) <0.001 40 (13) 39 (30) <0.001
 4th-generation cephalosporins; J01DH 8 (0) 23 (1) 0.032 0 (0) 0 (0) 0 (0) 9 (0) 0 (0) 0 (0)
Sulfonamide with timethoprim; J01E: J01EE 8 (0) 0 (0) 18 (1) 0 (0) 8 (0) 0 (0) 0 (0) 0 (0)
Macrolides, lincosamides; J01F 16 (1) 2 (0) <0.001 4 (0) 6 (1) 0.025 15 (0) 7 (0) 0.060 3 (1) 4 (3) 0.110†
 Macrolides; J01FA 12 (0) 2 0.002 4 (0) 6 (1) 15 (0) 7 (0) 3 (1) 4 (3)
 Lincosamides; J01FF 4 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Aminoglycoside; J01G: J01GB 78 (3) 73 (2) 0.090 149 (6) 46 (5) 0.364 17 (1) 60 (2) <0.001 11 (3) 9 (7) 0.102
Quinolones; J01M: J01MA 1031 (38) 301 (9) <0.001 731 (31) 112 (13) <0.001 1526 (48) 464 (13) <0.001 126 (40) 37 (29) 0.030
Fixed-dose combination of ABs; J01R: J01RA* 12 (0) 929 (28) <0.001 31 (1) 170 (20) <0.001 34 (1) 669 (19) <0.001 6 (2) 17 (13) <0.01
Other ABs; J01X 167 (6) 176 (5) 0.145 132 (6) 30 (4) 0.020 149 (5) 138 (4) 0.197 20 (6) 15 (12) 0.056
 Glycopetide ABs; J01XA 15 (1) 176 (5) <0.001 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
 Imidazole derivatives; J01XD 152 (6) 0 (0) 132 (6) 30 (4) 0.020 149 (5) 137 (4) 0.176 20 (6) 15 (12) 0.056
 Other ABs; J01XX 0 (0) 0 (0) 0 (0) 0 (0) 0 (0) 1 (0) 0 (0) 0 (0)
Drugs for treatment of tuberculosis; J04A 0 (0) 0 (0) 24 (1) 0 (0) 0 0 (0) 0 (0) 0 (0)
 Antibiotics; J04AB (treatment for tuberculosis) 0 (0) 0 (0) 6 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
 Hydrazides; J04AC 0 (0) 0 (0) 6 (0) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
 Other drugs for treatment of tuberculosis; J04AK 0 (0) 0 (0) 12 (1) 0 (0) 0 (0) 0 (0) 0 (0) 0 (0)
Nitroimidazole derivatives; P01AB (oral metronidazole) 201 (7) 0 (0) 81 (3) 3 (0) <0.001 132 (4) 1 (0) <0.001 15 (5) 0 (0)

Significant p values shown in bold.

Pearson χ2 and

†Fisher’s exact test was used to compare antibiotic prescribing details.

AB, antibiotics; ATC, Anatomical Therapeutic Chemical (classification); J01RA*, ATC code as assigned by Sharma et al.17 n (%), number of prescriptions (percentage in antibiotic class); NTH, non-teaching hospital; TH, teaching hospital.